Polymorphism of mixed cryoglobulinemia manifestations in hepatitis C virus chronic infection
https://doi.org/10.51523/2708-6011.2021-18-1-21
Abstract
Objective: to analyze the characteristics of hepatitis C virus chronic infection with concurrent cryogobulinemia, to assess the prevalence of extrahepatic diseases in the population of Belarusian patients under study.
Material and methods. An open, non-randomized observational study with the inclusion of patients with hepatitis C virus (HCV) chronic infection and cryoglobulinemia (CG) was conducted.
Results. The study has determined the core characteristics of HCV infection in CG patients, incidence rates and a wide array of extrahepatic diseases (EHDs), as well as HCV infection distinctive features compared to those without extrahepatic diseases.
Conclusion. The revealed variety of common EHDs in HCV infection indicates that many organs and systems are involved in the pathological process and this variety should be taken into account when considering prognosis and treatment tactics.
About the Authors
S. P. Lukashyk
Belarusian State Medical University
Belarus
Belarus
Svetlana P. Lukashyk, Cand. Sc. (Medicine), Associate Professor at the Department of Infectious Diseases, Minsk
I. A. Karpov
Belarusian State Medical University
Belarus
Belarus
Igor A. Karpov, D.Sc. (Medicine), Professor, Head of the Department of Infectious Diseases, Minsk
O. V. Krasko
United Institute of Informatics Problems of the NAS of Belarus
Belarus
Belarus
Olga V. Krasko, Cand. Sc. (Technology), Associate Professor, Leading researcher at the Bioinformatics Laboratory, Minsk
References
1. Falla AM, Hofstraat SHI., Duffell E. et al. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups. BMC Infect Dis. 2018;18:79. https://doi.org/10.1186/s12879-018-2988-x
2. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019 Jan;70(1):151-171. https://doi: 10.1016/j.jhep.2018.09.014
3. Kolopp-Sarda MN, Miossec P. Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin- Positive Patients: Detection and Characteristics. Front Immunol. 2020 Jun 30;11:1183. https://doi: 10.3389/fimmu.2020.01183
4. Kuna L, Jakab J, Smolic R, Wu GY, Smolic M. HCV Extrahepatic Manifestations. J Clin Transl Hepatol. 2019 Jun 28;7(2):172-182. https://doi: 10.14218/JCTH.2018.00049
5. Ignatova TM, Kozlovskaya LV, Gordovskaya NB, et. al. Hepatitis C virus-associated cryoglobulinemic vasculitis: A 20-year experience with treatment. Terapevticheskii Arkhiv. 2017;89(5):46-52. (in Russ.). https://doi: 10.17116/terarkh201789546-52
6. Zignego AL, Giannini C, Ferri C. Hepatitis C virusrelated lymphoproliferative disorders: an overview. World J Gastroenterol. 2007 May 7;13(17):2467-78. https://doi:10.3748/wjg.v13.i17.2467
7. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol. 1994 Oct;88(2):392-4. https://doi: 10.1111/j.1365-2141.1994.tb05036.x
8. Zhu X, Jing L, Li X. Hepatitis C virus infection is a risk factor for non-Hodgkin lymphoma: A MOOSEcompliant meta-analysis. Medicine (Baltimore). 2019 Mar;98(11):e14755. https://doi: 10.1097/MD.0000000000014755
9. Pelletier K, Royal V, Mongeau F, Meunier RS, Dion D, Jao K, Troyanov S. Persistent Mixed Cryoglobulinemia Despite Successful Treatment of Hepatitis C, Aggressive B-Cell-Directed Therapies, and Long-term Plasma Exchanges. Kidney Int Rep. 2019 May 7;4(8):1194-1198. https://doi: 10.1016/j.ekir.2019.04.022
10. Aydeniz A, Namiduru M, Karaoglan I, Altindag O, Yagiz E, Gursoy S. Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver. Rheumatol Int. 2010 Feb;30(4):515-7. https://doi: 10.1007/s00296-009-1010-8
11. Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med. 1997 Nov 24;157(21):2497-500. PMID: 9385302
12. Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007 Mar;45(3):797-805. https://doi: 10.1002/hep.21563
13. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646-469. https://doi: 10.1002/bjs.1800600817
14. Child C, Turcotte J. The liver and portal hypertension. BJS. 1964:51(11):879-879.
15. Milovanova SYu, Kozlovskaya LV, Gordovskaya NB. Polymorphism of clinical manifestations of cryoglobulinemia-related vasculitis associated with chronic hepatitis С virus infection. Almanac of Clinical Medicine. 2014;(30):46-51. (In Russ.). https://doi.org/10.18786/2072-0505-2014-30-46-51
16. Baĭkova TA, Lopatkina TN. A variety of extrahepatic manifestations of chronic viral hepatitis B and C: basic treatment principles. Terapevticheskii Arkhiv. 2013;85(4):106-110. (In Russ.).
17. Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic manifestations of chronic HCV infection. J Gastrointestin Liver Dis. 2007 Mar;16(1):65-73. PMID: 17410291
Review
For citations:
Lukashyk S.P., Karpov I.A., Krasko O.V. Polymorphism of mixed cryoglobulinemia manifestations in hepatitis C virus chronic infection. Health and Ecology Issues. 2021;18(1):160-169. (In Russ.) https://doi.org/10.51523/2708-6011.2021-18-1-21
Views: 377
Email this article 